Gene Query: PLTP

Dataset Description Geneva Score
Analysis by Whole Transcriptome Sequencing of the Effects of LLC1 conditioned medium, LLC1 conditioned plus Calcitriol, non-conditioned medium, and non-conditioned medium plus Calcitriol on mRNA Expression in Primary Human Skeletal Muscle Cells 125.09
Lung Cancer Cell-Mediated Skeletal Muscle Mitochondrial Dysfunction is Mitigated by 1a,25-Dihydroxyvitamin D3 125.09
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 70.1
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 61.15
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 58.3
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 56.64
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 53.13
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 52.19
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 49.52
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 48.83
In vivo genome editing restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers 47.99
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 46.87
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 46.87
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 46.77
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 46.06
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 44.86
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 44.11
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging 42.61
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 41.92
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 41.92
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 40.84
Recovery and analysis of nascent RNA 39.06
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 39.06
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 38.68
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 38.68
Generation and functional characterization of MDSC-like cells 38.33
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 38.26
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 37.17
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 37.1
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 36.28
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 35.59
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 35.3
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 34.67
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 34.35
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 33.58
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 31.7
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 31.57
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 31.5
Global Gene Expression Changes in Cholangiocytes Treated with TGF-beta 30.9
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 30.83
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 30.1
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 29.8
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 29.58
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 29.32
RNA-seq of stable and unstable section of human atherosclerotic plaques 28.97
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 28.83
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 28.16
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 27.76
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 26.95
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 26.95
SRSF2 mutations impair hematopoiesis and alter exon recognition 26.49
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 26.09
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 25.36
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 25.36
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 25.16
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 25.16
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 24.78
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 24.43
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 24.41
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 24.08
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 23.72
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 23.5
Molecular Mechanisms of Endothelial Hyperpermeability 23.47
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 23.1
Ectoderm specification of H1 human embryonic stem cells 22.91
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 22.84
Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures 22.78
RNA-sequencing of human tendon after injury 22.77
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 22.74
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 22.53
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 22.32
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 22.32
Integrin signaling regulates YAP/TAZ to control skin homeostasis 22.25
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 22.02
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 21.78
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 21.78
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 21.5
Lysine benzoylation is a novel histone mark 21.46
Lysine benzoylation is a novel histone mark [RNA-seq] 21.46
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 21.43
The regulartory role of ZCCHC24 in splicing machinery 21.36
Differential expression of genes in AD169-infected MRC5. 21.12
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 21.03
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 20.9
Human T-cell lymphoblastic lymphoma samples and control thymuses 20.84
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 20.84
Redifferentiation of expanded human islet β cells by inhibition of ARX 20.74
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 20.71
Effect of mitochondria deficiency on senescence-associated gene expression 20.68
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 20.43
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 20.31
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 20.23
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 20.17
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 20.16
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 20.03
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 20.03
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 19.99
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 19.93
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 19.92
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 19.77
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 19.71
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 19.66
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 19.31
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 19.2
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 19.2
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 19.07
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 19.03
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 18.97
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 18.82
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 18.59
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 18.5
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 18.18
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 18.13
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 18.0
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 17.84
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 17.84
Differences in miRNA Detection Levels are Technology and Sequence Dependent [NGS] 17.79
Differences in miRNA Detection Levels are Technology and Sequence Dependent 17.79
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 17.77
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 17.77
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 17.72
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 17.63
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 17.59
Transcriptome analysis of U87 cells upon LINC00152 knockdown 17.4
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 17.4
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 17.38
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 17.36
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 17.36
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 17.2
Gene expressions of H9s in different culture systems 17.07
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 16.98
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 16.94
Chromatin landscape of human visceral and subcutaneous adipocytes 16.91
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 16.88
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 16.83
RNA-seq of young and quiescent MRC-5 human fibroblasts 16.77
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 16.74
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 16.6
Next Generation Sequencing Compares Effects of microRNA-9 perturbation in control and SZ hiPSC NPCs 16.47
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 16.36
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 16.22
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 15.94
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 15.87
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 15.86
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 15.86
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 15.85
CHD1 regulates cell fate determination by activation of differentiation-induced genes 15.78
Neurofibroma 15.68
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 15.68
Tumor exosome integrins determine organotropic metastasis 15.63
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 15.54
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 15.53
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 15.44
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 15.38
Gene expression changes in human melanoma cell lines compared to primary melanocytes 15.37
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 15.34
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 15.32
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 15.25
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 15.22
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 15.22
RNA-seq of human fibroblasts after irradiation 15.09
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 15.07
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 14.93
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 14.92
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 14.74
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 14.69
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 14.67
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 14.57
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 14.56
BAF controls genome accessibility 14.49
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 14.49
Neonatal and adult human testis defined at the single-cell level 14.41
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 14.39
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 14.31
A prostate cancer chromatin interaction map 14.31
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 14.22
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 14.11
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 13.99
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 13.81
Transcriptome wide analysis of classically and alternatively activated macrophages 13.8
The role of FAM46C in myeloma cells [sequencing] 13.77
The role of FAM46C in myeloma cells 13.77
RNA-seq analysis of AML cells in response to ASLAN003 13.77
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 13.68
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 13.63
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 13.63
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 13.62
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 13.61
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 13.57
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 13.56
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 13.51
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 13.5
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 13.5
Cleavage Factor Im as a key regulator of 3’ UTR length 13.5
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 13.44
Transcriptomic profile of human embryonic renal corpuscles 13.39
RNA-seq analysis of uveal melanoma cells treated with FR900359 13.38
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 13.31
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 13.21
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 13.21
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 13.21
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 13.2
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 13.2
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 13.2
Morphological and molecular characterization of human dermal lymphatic collectors 13.18
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 13.11
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 13.08
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 13.07
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 12.98
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 12.98
Transcriptome analysis reveals differential splicing events in IPF lung tissue 12.95
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 12.94
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 12.68
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 12.65
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 12.65
RNA-seq analysis upon ARID1B overexpression 12.62
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 12.58
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 12.51
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 12.49
DIGIT regulates endoderm differentiation of human embryonic stem cells 12.44
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 12.39
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 12.39
High-Throughput Kinetic Analysis of Fractional Killing 12.34
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 12.25
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 12.04
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 11.99
Global expression profiles in cardiac progenitor cells generated by ISX-9 11.9
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 11.9
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 11.89
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 11.87
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 11.71
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 11.67
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 11.65
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 11.64
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 11.56
Functional astrocytes differentiated from hiPSCs 11.51
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 11.49
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 11.38
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 11.37
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 11.15
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 11.02
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 10.89
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 10.87
Subtle asymmetry of gene expression in embryonic and foetal human brains 10.84
RNA-seq analysis of the human fetal kidney. 10.82
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 10.75
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 10.74
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 10.69
Cerebellar differentiation in Ataxia-Telangiectasia 10.68
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 10.6
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 10.54
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 10.49
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 10.45
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 10.39
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 10.35
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 10.25
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 10.13
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 10.11
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 10.07
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 10.02
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 10.02
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 9.93
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 9.93
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 9.81
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 9.77
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 9.76
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 9.64
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 9.64
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 9.63
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 9.55
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 9.43
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 9.42
RNA sequencing of human pancreatic cancer cell lines 9.19
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 9.14
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 9.07
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 9.04
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 9.04
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 8.92
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 8.92
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 8.92
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 8.85
Transcriptome profiling of Normal and Cancerous Prostate Cells 8.84
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 8.83
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 8.83
Expression profiling of etoposide-induced senescent cells 8.8
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 8.78
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 8.78
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 8.7
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 8.52
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 8.34
iPSC-Derived Cholangiocytes 8.33
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 8.28
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 8.27
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 8.22
RNA-seq of IL-4 stimulated human keratinocytes 8.16
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 8.15
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 8.09
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 8.06
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 8.04
Activity-dependent transcriptional changes in human neurons 7.95
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 7.89
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 7.83
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 7.83
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 7.8
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 7.8
Alteration of the microRNA network during the progression of Alzheimer’s disease 7.78
Single cell transcriptome of peritoneal cells 7.74
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 7.74
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 7.67
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 7.67
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 7.65
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 7.61
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 7.49
Regionally specified human pluripotent stem cell-derived astrocytes 7.48
Genome-wide transcriptional response to random aneuploidy in human cells 7.45
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 7.37
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 7.37
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 7.3
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 7.3
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 7.29
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 7.23
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 7.22
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 7.19
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 7.19
FGF2 regulation of gene expression in stable inducible Neurons 7.05
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 7.02
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 6.91
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 6.91
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 6.85
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 6.85
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 6.84
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 6.77
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 6.58
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 6.58
Gene expression of collecting duct carcinoma of the kidney 6.43
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 6.4
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 6.3
A practical evaluation of alignment algorithms for RNA variant calling analysis 6.28
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 6.26
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 6.24
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 6.23
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 6.18
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 6.14
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 6.14
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 6.1
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 6.07
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 5.96
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 5.96
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 5.95
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 5.94
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 5.92
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 5.82
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 5.77
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 5.67
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 5.45
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 5.43
Gene expression patterns define the hepatocyte-like cells derived by different strategies 5.4
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 5.4
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 5.33
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 5.32
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 5.31
RNA-seq in endometrial stromal tumors 5.3
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 5.25
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 5.24
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 5.23
RNA seq with AML (NB4) cells upon FTO inhibition 5.08
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 5.07
RNA-Seq of Breast and Ovarian Cancer Cell Lines 5.03
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 4.9
N6-methyladenine DNA Modification in Glioblastoma 4.9
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 4.82
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 4.77
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 4.74
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 4.57
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 4.56
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 4.55
Differential gene expression of human melanoma cells [RNA-seq] 4.55
Gene expression profile in breast cancer cell lines using RNA sequencing 4.54
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 4.5
Human optic chiasm from healthy controls and multiple sclerosis patients 4.5
Multiple sclerosis and EAE 4.5
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 4.47
Transcriptome of EBV-infected gastric cancer cell lines 4.44
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 4.32
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 4.29
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 4.28
Transcriptome Analysis and Functional Identification of Adipose-Derived Mesenchymal Stem Cells in Secondary Lymphedema 4.24
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 4.24
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 4.22
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 4.21
Global epigenomic reconfiguration during mammalian brain development 4.13
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 4.05
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 4.0
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 3.96
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 3.96
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 3.96
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 3.93
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 3.93
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 3.9
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 3.79
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 3.79
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 3.76
Effect of from Human Umbilical Vein Endothelial Cells 3.75
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 3.68
circRNA profile in hypopharyngeal cancer 3.68
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription [RNA-Seq] 3.68
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription 3.68
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 3.66
Common inflammatory pathways between NEC and Crohn's disease 3.55
Transcriptome profiling of 5 human adenocarcinoma cell lines 3.55
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 3.47
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 3.45
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 3.41
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 3.35
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 3.27
Transcriptomic analysis of human macrophages in 3D 3.26
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 3.23
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 3.15
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 2.99
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 2.98
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 2.91
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 2.91
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 2.87
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 2.82
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 2.74
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 2.71
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 2.71
Hepatic transcriptome of pediatric hepatoblastoma. 2.7
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 2.65
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 2.61
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 2.52
RNA-Seq of the corpus callosum from 12 individuals 2.42
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 2.4
Postnatal lipids drive hepatocyte maturation 2.39
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 2.31
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 2.25
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 2.21
Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord and chorionic plate under serum-free condition 2.11
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 2.09
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 2.05
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 2.02
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 1.95
Deep RNA sequencing of the human placental transcriptome 1.94
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 1.91
Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons 1.89
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 1.8
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 1.73
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 1.69
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 1.68
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 1.68
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 1.67
RNA splicing alteration on glioblastoma and normal neural stem cells 1.58
Aortic Valve Tissue: Stenosis vs. Sclerosis 1.49
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 1.47
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 1.47
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 1.42
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 1.41
Transcriptome profiling of de-differentiated chondrocytes over-expressing miR-138 or miR-181ab1 during osteogenic induction 1.4
Human islets of varying quality: the good, the (not so) bad and the ugly 1.34
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 1.29
Gene expression profile of human placenta from T. Cruzi infected mothers 1.29
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 1.2
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 1.2
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 1.18
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 1.15
Gene expression of thyroid cancer cell lines 1.14
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 1.05
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 1.04
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 1.03
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 1.03
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 1.02
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 0.9
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 0.8
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 0.76
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.68
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.68
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 0.51
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 0.51
Macrophage Ad5f35 PhenoMap 0.5
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 0.45
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.44
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 0.39
RNA expression profiles comparing primary and omental ovarian carcinoma samples 0.39
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 0.37
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 0.31
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 0.31
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 0.31
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 0.24
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 0.24
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 0.19
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 0.15
iPSC derived motor neuron cultures from C9ORF72 carriers 0.11
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 0.09
JunB control of keratinocyte-mediated inflammation [RNA-seq] 0.06
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 0.06
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 0.06
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 0.06
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.03
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 0.03
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation